Europe opens the door, China half-closes its own
Lilly's Foundayo weight-loss pill clears Europe's key hurdle, Beijing floats a ban on foreign takeovers of its biotech platforms, and AbbVie and BMS join the 340B court fight. When the rules change, so does the way you win.

